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ABSTRACT 
The presence and biochemical characteristics of human brain natri· 
uretic peptide (hBNP) in the amniotic fluid at various gestational ages 
were investigated. The hBNP-like immunoreactivity (hBNP-LIJ levels 
in amniotic fluid, determined by RIA, were 118.7 ± 57.6 pmol/L (mean 
± SEM; n = 5) and 107.7 ± 8.7 pmol/L (n = 9) in the first and second 
trimesters of pregnancy, respectively; it was significantly decreased to 
28.4 ± 5.1 pmol/L (n - 9) in the thtrd trimester. However, human 
atrial natriuretic peptide-like immunoreactivity (hA:-.IP-LIJ was not 
detected (<0.3 pmol/L) in an) of these samples. Nonhern blot analy~i~ 
demonstrated hBNP mR 'Am human amnion tissue. Moreover. cui-
BRAI natnuretic pephde (B P), a novel natriuretic, di -uretic, and smooth muscle relaxant peptide originally 
isolated from the porcine bram, has a structure highly ho-
mologous to that of atrial natriuretic peptide (Al\ P), and has 
biological functions similar to those of ANP (1, 2). We 
previously reported that B P is synthesized in the porcine 
and rat heart and is secreted into the circulation as a cardiac 
hormone {3, 4). Recently, we isolated human BNP (hB P) 
from human atrium and established a specific RIA for hBNP 
using a monoclonal antibody against hBNP (2, 5, 6). We 
subsequently revealed that hBNP is mainly secreted from 
the ven tricle and that the synthesis and secretion of hBNP 
in the heart are increased in patients with cardiovascular 
diseases, such as congestive heart fa ilure (5, 6). 
During normal and pathological pregnancies, significant 
hemodynamic alteration occurs, with drastic changes in the 
levels of various vasoactive hormones (7). Among these 
hormones, A Pis reported to be involved in the homeostasis 
of maternal and fetal circulations (8, 9). 
We previously demonstrated the presence of A!\:P in the 
rat brain (10), and Gardner e/ a/. (11) detected ANP mRl\A 
in extracardiac tissues, such as rat lung and pituitary gland 
Moreover, A P may be related to hormone secretion, such 
as aldosterone secretion from adrenal gland and vasopressm 
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tured amnion cells ~ecreted a stgmficant amount of hBNP-LI ( 100 200 
fmol/10" rells/da) ), hut not hANP Ll, into the culture medium. The 
svnthesis of hBNP in cultured amnion cells was further confirmed 
u'sing the polvmera~e chain reaction. High performance gel permeatwn 
chromatography of hf-INI' L1 extrac1ed from human amniotic fluid and 
the culture medium ot amnion cells revealed that the predominant 
molecular form of hBl\P L1 in both samples was the hBl\'P precursor, 
with an approximntt· mol w1 of 12 kilodaltons. 
Tht-se findm!(s indicate thai hB:'\P is present in the human amniotic 
fluid. and that amnion ct.'lls synthesize hB'\P and secrete it into the 
amniotil' t'avit~ . f,J C/in Endocrmol ,'\fl'tab 76: 907 -911, 199:Jl 
secrl'hon { n>m thl' pituitary ( l 2- 14 ). Recentlv, it \,-a., reported 
that hA' P wa ... tn\'Ol\'t>d m watt>r and ... odtum absorptiOn 
across tho..> mtt>stine { 15, 16) and that B'P stimulated phoo.,-
phate secn•tion from porcim• colon ep1thehum (17). I iowe\'er, 
no information io., a\ ail,lbll' on the implication of natriuretic 
peptides 111 tht> rt>gulatwn of amniotic fluid \'Olume which is 
essen hal for the fetuo., to o.,urvi\ e 
In the pre'>l'nt o.,tud\, to imestigate the pre~ence of natri 
uretic peptidt''> 111 the ammotlc ca\'ltv, we measured hB!\iP 
like immunort•acll\.il\ (hBNP-1 I) and hANP-li"e 1mmuno 
reactiv1tv (hANP Ll) 111 the amn1otic fluid at various gesta 
tiona! ages bv RIA. We also measured the secretion of hBNP 
Ll from amnion cells 111 primary culture and demonstrated 
the gene exprc'>smn of hBNP in amnion tissue and cultured 
amnion celb bv Northern blot analysis and pol) merasc cham 
reaction, rcspt•ctiH•ly. 
Materials a nd Methods 
Collel'lum of amnwti1 /had 
Amnwt!l" flutd 'ampll-~ \H'W C<>lil-dl'd afto:r ro:ct'i\·inf; an formed nm-
't'nt Jl tht• hmt• of tht•rJpt•uhl' aborhon, dt.l~no~hc ammoct>ntt'"' and 
ce.,drt'Jll wclwn Jt \ anou' g,·,t.JhonJl Jg<''> :\'one oi tht• womt>n hc~d 
compiKJh<>n' of hypl·rtt•n'olon or cc~rdtm ,,,cular dt.,ea'"'' Sampk' wt>re 
tmmt'dtatl'l\" trJn,ferrt·d mtt> chtllt•d 'tlicomzed gla'~ tub.:, contammg 
aprohnm ( 1000 J..,Jihkrt>m mhtbttor umt'o/ mL) and EDT A dtsodtum .. .~It 
{I m~/mL). mt'l.t•d g<·ntly, ,md ct·nlnfug._.d dt 1500 x s for 20 mm at 4 
C The 'upt·rnatJnt wa' 'ton·d ,lt - 20 C until a .. .,ay. 
Collectwn and preparation of tis ... ue 
Ammon, chonon lat'\'l', dcc1duJ vera tissue, and chorion plate Wt'rt' 
separatl'd from plan•ntat• obtamed b\· normal vaginal dehvery at tt'rm 
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and by aborllon'> m the first and -.econd tnml><;tero; (I 2, 13 14 20, and 
23 week'> ~t..,tahon). Human ventricular hs,ue wa~ obtamed from pa 
hent!> without cardtovasrular comphcallon~ at the time of autopsv for 
patholo~Kal exammahon These samplt•., were tmmediately frozen m 
ltqutd nttrogen and stored at -70 C until tht• l'Xtrachon of BNP or total 
RNA 
Extractton of BNP from amnion ttssuP was c~rried out as described 
previously (b) Thi~ e>.tract was used fur thl' RIA of BNP-LI in amnion 
tis~ue~ 
Cultun· of human amnion cPIL\ 
A pnmal)· culture of human ammon cells was conducted according 
to thc mcthod dcscnbed by Oktta t'l a/. ( Hl) . After filtration of the 
dt.,pcrwd ammon cells through 2 ·mm and 300-pm mesh, amnion cells 
m the filtrate were resuspended at a concentr,lhon of 2 X 10' cells/mL 
m Dulbccw'~ Mmtmum Essential Medium contammg 10% fetal c.1lf 
serum .mJ set.>dt'd on a gelilhn coated dt.,h Thc mcubation was con 
ductt'd under the atmosphere of sri C02 m atr at 37 C. Every 2 days, 
.m .11iquot of the medium was sampled and '>tored at -20 C until assay 
for hBNP II and hANP-LI, then the ml•dium wa~ changed to fresh 
Dulbccco·~ Mmtmum Essential Medtum cont;:unmg I 0"<. fetal calf serum 
The punty of cultured ammon cclls wa" cJ<ammed by immunohtsto-
chcmtcal stammg for cytokeratm, vtml'nhn, o~nd CA19-9 (19, 20) Tht.> 
pattern of •mmunohtstochemtcal stammg for these ~ub~tances in thc 
cultured ammon cells was the samt.> •"' that ub~erved m the ammon 
eptthl'ltum 111 ;.rill (19 20) 
RIA for hBNP and hANP 
Tht• RIA fur hBI\P wa!> pcrlurmcd u~tn~ a ~peofic monoclonal 
.mttboc.lv (KY hBNP I) to hBNP, a~ dc.,cribed previou~lv (5. 6) In soml' 
sampleo,, hBNP L1 was extracted with a Scp Pak C,. cartridge (Water~ 
A~suciate~. Mtlford, MA). The cross reachvtty of this RIA to hANP was 
leso, than 0.005'1 on a molar bast>. The mtmmum dl'tectable quantity 
was 0 3 fmol / tube, and the 50% binding rntl•rcept was 3 (mol/tube. The 
RIA for hANP wa~ performed a., prcviou~l\' reported (21). The cross· 
reachvuv of RIA for hA:\P to hB;-,;r was ll'~' than 0.01 't on a molar 
basts hB' P and hA \JP were purchased from Peptide Institute Inc 
(Mmoh Japan} All other reagent~ used wt.>re of analytical grade 
H1gh performance gel permeatiOn chromatography (HP-GPC) 
The e><tracts. obtamed w1th a Sep-Pak C 1, cartridge from amniottc 
flUid or culture medium of amnion cells, were o,ubjected to HP-GPC on 
a TSK Gf.L G2,000 SW column (7 5 x 600 mm, Toyo Soda, rokvo, 
Japan) Tht' column was eluted with 1 0 mM tnfluoroacetic acid contJin-
ing 0.3 M .,od1um chloridt! and 30% acetunttnle as a solvent (6, 22). 
Northern blot anol)si.<> of hBNP mRNA and hANP mRNA 
Total R'A was extracted from ussut>~ 1n -1 '1 guamdJUm thiocyanate 
buffer 'orthem blot analvsts was earned out usmg the hB!\:P and 
hA'P cD'A probes, as pre\'lously de'>cnbed (23- 25) d-AClln mR\JA 
levels were demonstrated to be equtvalent among d1fferent RNA sam 
pies, u\mg human ii-actin genom•c probe (Wako Pure Chermcal Indus 
tries Ltd., O~aka, Japan). 
Polymera.w! chain reaction (PCR) 
To conftrm that BNP ts actually synthe,11ed m cultured ammon cells, 
the PCR was camed out. Total R A wa.,l•xtrJcted from rultured amnrun 
cells at thl' hme they reached confluencc and I 0 days after reachmg 
conflut:ncc .JS wl.'ll a:. from the ventricular ho,.,ue of the heart. as descnbed 
above. After reve~e transcnphun of 5 pg of tht">l' total R'A bv oligo(dT) 
pnmtng and Molone,· munne leukcm1a \'lruo, reverse transcriptase (Be-
thesda Rc.,l'arch Laborator, , Gatlhl'r.bl·rg. \10). the resultmg smgle 
strandt'd cD"-A was ~obJected to PCR U'tng pnmer:. dt'Scnbed prt>\'1-
ou,ly (4, b. 25) 
Stat1Mical analysis 
JCE & "1• 199:1 
Voi76•No• 
Stah!>trcal analysis of the data wa~ pt.>rformed by Student's t te.,t or 
.1no~lysis of variance where appropnate. All values were expressed as thr 
m1.•an ± SEM. The number of observations is indtcated in parentheses. 
Resu lts 
hBNP-LllPuel in amniotic fluid 
The dilution curve of amniotic Ouid paralleled the standard 
curve of hBt P. hB\JP-Ll levels in the amniotic Ouid of the 
first and second trimesters were 118.7 ± 57.6 pmoi/L (mean 
± SEM; n = 5) and 107 7 ± 8.7 pmoi/L (n = 9), respecti,·ely 
In the third trimester, the hB P Lllevel in the amniotic Ouid 
wa-. 28.4 ± 5.1 pmoi/L (n = 9), which was significantly (P < 
0.0 l) lower than those in the first and second trimesters. In 
contrast, hANP-Ll was not detected (<0.3 pmoi/L) in any 
amniotic Ouid samples examined. 
hBNP-Llleuel in the amnion tissue and synthesis of hBNP in 
amnion t~~sue 
To investigate the source of hB P in the ammotic Ouid, 
we measured hB, P-LI level!. m the extracts from amnion 
tissues. The hB P-LI level tn the amnion tissue was 262 ± 
59.5 fmol/g tissue (mean ± sEM; n = 3) in the second 
trimester. However, the hB P-LI level in the amnion tissue 
at term was less than 90 fmol/g tissue (the lower limit of 
delectability) in all three samples examined. On the other 
hand, hANP-Ll levels in the extract from the same amnion 
tissues were less than 90 fmol/g tissue (the lower limit of 
detectability) in both the second trimester and at term. To 
confirm further the synthesis of hB lp in amnion tissue, Wl' 
measured the hB. P mR A lt~,·el m amnion tissues in the 
second trimester and at term, chononic plate at term, chorion 
laevc at term, and decidua vera m the second trimester and 
at term. In amnion tissue tn the second trimester, orthem 
blot analysis using the hBNP eDNA probe identified a single 
mRNA band of the same si7c as the hBNP mRNA from the 
human ventricular tissue (Fig. I). However, no hybridizing 
band of hBNP mRNA was detected in the other tissues 
examined. By contrast, no hybridi7ing signal of MNP mRNA 
was detected in any of the tissues examined. 
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F'tG. I. Detection of hBNP mRNA in the human amnion \tssue by 
Northern blot analysis. Northern blot analysis of hBNP mH A and 
hANP mRNA from decidua tissue at term (lane 1) and in the ~econd 
trimester (lane 2). placenta at term (lane 3), chorion laeve at term 
(lane 4). amnion tissue at term (lanP li) and m the second trimester 
(lane 61. and hean (lane 7) was performed as de!'Cribed in MaterraL~ 
and MPthod~. Twenty m1crogram~ of total RNA were used in each lane 
The relative amount of d-Actin mRi\A in each sample was determined 
by rehylmdizauon of the plate. Kh, Kilobases. 
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Synthesis and secretion of hBNP b.' cultured amnion cPIL\ 
The dilution curve of culture medium of ammon cells also 
paralleled the standard curve of hBNP. To investigate the 
synthesis and secretion of hBNP from amnion cells, we 
measured hBNP-LI levels in the culture medium of amnion 
cells. The hBNP-Ll level in the culture medium remained 
low until the amnion cells reached confluence. llowever, the 
hBNP-LJ level increased several days after reaching connu -
ence. Ten day!> later, the hB P-Lilevel in the culturt> medium 
after 48 h of incubation was 151.9 ± 18.8 pmoi/L (mean ± 
SEM; n = 5). From the changes m the hBNP-LI level in the 
culture medium, the rate of hB!\:P synthcc;t~ by cultured 
amnion cells was calculated. The rate of hB r '>ynthesis on 
the tenth day of confluence was 188.9 ± 24.9 fmol/ I Ob cells· 
day (n = 5, Fig. 2). By contrast, hANP-LI was not detected 
(<0.3 pmoi/L) in the culture medium or amniotic Ouid. 
To further confirm the synthesis of hBNP in the primary 
culture of amnion cells, PCR was carried out. The PCR 
successfully amplified a single size fragment of the predicted 
size (462 basepatrs), visuali7ed by ethidium bromide staining, 
using cD As from amnion cells 10 dav'> after reaching 
confluence as well as those from heart, whtle no amplifica-
tion was observed using cD TAs from ammon cells at the 








.. 100 0 
0 50 
.§ 
10 1 2 1 4 II I I 20 22 2 4 21 
day of culture 
Ftc. 2. Time course of hBNP-Ll secretion from amnion cell~ in cui· 
ture. Amnion cells reached confluence on the seventh day of culture. 
Hatched column..~ and tertical bars represent the mean and SEM of 
hBNP-LI secreted per 10• cells/ day in fh·e dishes. 
1 2 3 4 
Ftc. 3. Detection of hBNP mRNA in the cultured amnion cells by 
DNA PCR. The total RNA extracted from cultured ammon rells at the 
time they reached confluence (lane 2) and 10 day-. aft!'r reaching 
confluence (lane 3) and from hean (lane 4) were u~ed After reverse 
t ranscription of 5 ,.,g total RNA, the resulting cO :-.lA was ~ubj('Cted to 
PCR, and the PCR product was fractionated on a 1.4'·, al{aro~e gel and 
visualized by ethidium bromide staining. The positions of si7e markers 
lrJ>x/Haelll; lane I) are shown on the left. 
Molecular form of hRSP-LI in amnwtic flwd and culture 
medtum of amni()n eel/., 
The molecular form of hBI\lP Ll m the t:\tract<> from the 
second trimestt.>r amniotic Ouid and tlw culture medlltm of 
amnion cells wa:. analyzed by HP-GPC As shown tn Fig. 4, 
hBNP 11 in both -.amples was eluted in t1 ~ingle peak. with 
an appro,imate mol wt of 12 kilodalton'>, corresponding to 
the hB P precur<>or. A similar pattern w.1s ob~erved when 
the same sample-. were assayed u-.ing another anti-hBI\:P 
antibod\ wtth dtfferent specificities (data not <>hown) 
Discussion 
The present .. tud) demonstrated that hBI\..P is present m 
human amnmttc fluid, wrule the hAN P Ll le\ el \\as below 
assay sensitivtty. The hBNP-LI level in amntotic iluid was 
much higher (10- to 100-fold) than tho-.e in third trimester 
maternal plasma and umbilical venouo., plasma (-2 3 pmol/ 
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FtG. 4. 1\.piral liP GPC profiles of the hHl\1' -l. ll'xtracted from the 
amniotic fluid and culture medium of amniou n·JI~. A. Extracts from 
amniotic flu1d of normal pregnane~ 10 t ht> ~t-rond t mne~ter. B. Extract~ 
from the supernatant of primary rultur~ uf amnion cell~. e. hB~P-LI 
in each fraction of HP-GPC': 0 . hA:\P Ll. In hoth !:').tracts hA~P-Ll 
was belo" the a~~ay .. en,.iti\'ltY in all fraction~ rh~ flow rate wa~ 0 3 
mL.'min, and the fraction volume wa-. n.:1G mL \'o, \'01d \'Oiume, \'t, 
total volume. 
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was approximately 0.7 pmol/L, much lower th.:m that in the 
amniotic fluid (ltoh, 1-l ., l\ Sagawa, and K. aJ..ao, unpub-
lished findmg). Moreover, the predominant molecular form 
of hBNP-Ll in the amniotic fluid, the hBNP precursor with 
an approximate mol wt of 12 kilodalton'>, was quite different 
from the molecular form of hB P-Ll in adult plasma (mainly 
3 kilodaltons) (6). These findings suggest that such a high 
hBNP-LI level in the ammotic flutd doe~ not originate from 
maternal plasma or fetal urine. The secretion of hBNP from 
the cultured amnion cells indicates that hBNP-Ll in the 
amniotic flu1d origmates from the amnion cells. The synthesis 
of hBNP m amnion tissue and cultured amnion cells was 
confirmed by Northern blot analysis and the PCR technique. 
This is the first report on BNP gene expression in tissues 
other than heart (25) and brain (1 ). By contrast, hANP mRNA 
was not detected by this method in anv samples examined. 
ln the present <>tudv, hBNP mRNA was detected only in 
amnion lls:,ue in the second trimester and in cultured amnion 
cells 10 day~ after reaching confluence, but not in amnion 
tissue at term or in amnion cells at the time thev reached 
con fluence The regulatory mechantsm of hBNP ge;1e expres-
sion m amnion cell!, i5 not clear at prest:>nt. The amnion tissue 
tS avascular ti'>sue and relativelv free from the circulating 
hormones. Therefore, mvcstigation of the synthesis and se-
cretion of tht• hBNP in cultured amnion cells may provide 
additional information on the regulation of hBNP synthesis 
and !>ccret10n. 
It i~ not known whether hBNP ~vnthe~i;ed in the amnion 
cells can permeate ft!tal membranes into the neighboring 
tissues, such as decidua, placenta, or myometrium. In our 
prelimmary experiment, a high hBNP-Ll level was found in 
the fluid of extraembryonic coelom in two ca~es of first 
trimester abortion (338.2 and 79.1 pmol/L). These levels 
were similar to those in the amniotic fluid of the same 
patients. This ftndmg may indicate that the hBNP precursor 
synthesi;ed in ammon cells can permeate the amniotic mem-
brane and reach the t1ssueo:; neighboring the amniotic cavity, 
such as chorion, decidua, placenta, and myometrium. Al-
though it is not known whether the hBNP precursor binds 
to natriuretic peptide receptors in these tissues, natriuretic 
peptide receptors are present tn placenta (28, 29). Moreover, 
in our preliminary experiment, the natriuretic peptide recep-
tors were identified in dectdua vera tissue (ltoh, I!., N 
Sagawa, and K. Nakao, unpublished observation). Taken 
together these findings lead U'> to speculate that the large 
amount of hBNP secreted from amnion cells exerts biological 
activity on tissues surrounding the amniotic ca'vity For ex-
ample, hBNP secreted from amnion ct•lls may regulate am-
niotic fluid volume by modulating the transport of electro-
lytes and water across the fetal membranes. Another possi-
bility is that hBNP may reach the decidua and myometrium 
and play some role in the prevention of initiation of preterm 
labor by relaxing the uterine myometrium until term, when 
the hBNP-Lllevelm amniotic fluid 1s significantly decreased. 
Further investigation on the characteri7ation of natriuretic 
peptide receptors in the tissues of amnion, chorion lacvc, 
decidua vera, myometrium, and placenta, as well as the 
biological activit\' of the hBNP prt:!cursor should provide 
more information on the biological significance of hBNP in 
human amniotic fluid. 
Finally, this primary culture system of amnion cells may 
serve as a useful model in investigating the regulation of the 
synthesis and secretion of hBNP, since amnion cells secrete 
only hBNP, in contrast to cardiocytes, which secrete both 
hANP and hB P. 
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Prmr<d"' L S A 
Transforming Growth Factor-11 Stimulates, and 
Glucocorticoids and Epidermal Growth Factor Inhibit 
Brain Natriuretic Pep1tide Secretion from Cultured 
Human Amnion Cells* 
HIROAKI ITOH, NORIMASA SAGA WA, MASAAKI HASEGAWA, KUMIKO INAMORI, 
HIROHISA UEDA, KYOKO KITAGAWA, HIDETAKA NANNO, YOSHIYUKI IHARA, 
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ABSTRACT 
We previously reponed the ma!>sive secretion of brain natriuretic 
peptide (8 P ) from human amnion cells and suggested the possible 
role of BNP in the maintenance of human pregnancy. In this study, to 
eluc1date the regulatory mechanism of BNP secretion from amnion 
cells, we measured the BNP level in the culture medium of amnion 
cells by RIA after incubation in the presence of various s•ubstances. 
Among the agents examined, cortisol (I x 10 7 to 1 x 10-6 moi/L), 
dexamethasone (1 x 10-8 to I X 10 " moi/L), and epid!!rmal growth 
factor (EGF; 2 x 10-" to 2 x 10-A moi/L) inhibited BNP secretion 
from the cultured amnion cells in a dose-dependent manner. By con-
WE PREVIOUSLY found that brain natriuretic peptide (B P), a second natriuretic peptide with natriuretic, 
diuretic, and vasodilative properties (1}, was secreted from 
the porcine and rat heart as a cardiac hormone (2, 3). We 
subsequently isolated human B P from human atrium and 
established a specific RIA for human B P (4-6). Using this 
specific RIA, we have demonstrated that BNP is predomi-
nantly synthesized in and secreted from the ventricle, and 
that the plasma concentration of BNP as well as that of atrial 
natriuretic peptide (ANP) are significantly increased in pa-
tients with cardiovascular diseases (5, 6). These findings 
suggest the importance of B P as a ca rdiac hormone. Re-
cently, we found that the plasma B P level is markedly 
elevated in women with pregnancy-induced hypertension 
(7) and in the umbilical vein of newborns with fetal distress 
(8), suggesting the pathophysiological importancE' of B P in 
the maternal and fetal circulations during pregnancy. 
Subsequently, we found that a high level (-llO pmoi/ L) 
of BNP, 50-fold higher than that in maternal or fetal plasma, 
is present in human amniotic fluid in the first and second 
trimesters of pregnancy, whereas the ANP level is below 
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trast, transforming growth factor-rl CTGFI:I; 4 x 10-11 to 4 x 10 '9 mol/ 
L) caused a 3- to 5-fold increase an B:\P secretion. TGFd-augmented 
B ' P ~ecretion was abolished by the addition of conisol or EGF to the 
culture medium. 
Moreover, in this study, we re\ ealed the presence ofbioacti\·e TGF.-J 
in human amniotic fluid (-4 x 10 10 mol/ L). The present lindjng of 
tight regulation of BNP secretion from amnion cells by cortisol, EGF 
and TGF,8, all at the concentrations physiologically present in human 
a mniotic fluid, implies a physiological role of BNP secretion from 
amnion cells in the pregnant uterus. (J Clin Endocrinol Metab 79: 
176 182, 1994) 
assay sensitivity (<0.3 pmoi/L) (9}. The BNP level in amniotic 
fluid decreases in the third trimester of pregnancy to one 
fou rth of that in the first and second trimesters (9). t orthern 
blot analysis revealed that the B P messenger ribonucleic 
acid was detected in amnion tissues during the second trimes-
ter, but was not detectable in the third trimester. Further-
more, human amnion cells in primary culture have been 
shown to secrete a large amount of BNP into the culture 
medium (9}. Thus, we have concluded that the BNP in 
amniotic fluid mainly originates from amnion cells, and BNP 
synthesis in amnion cells decreases in the third trimester, 
suggesting the role of B P in the maintenance of human 
pregnancy (9). 
In this study, to elucidate the regulation of B P secrehon 
from amnion cells during pregnancy, we examined the effects 
of various substances, which are present in human amniotic 
fluid and postulated to be important for the maintenance of 
pregnancy, on BNP secretion from cultured human amnion 
cells. As we and others have demonstrated that human 
amniotic fluid contains endothelin-1 (ET-1 ), a potent vaso-
constrictor, and ET -1 is secreted from cultured amnion cells 
(10- 12), we simultaneously measured ET-1-Iike immuno-
reactivity (ET -1-LI) in the culture medium for comparison. 
Materials and Methods 
Reagent 
Human B 'P, ET-1, and ET 3 were obtamed from Peptide Institute 
(Mtnoh, Japan). Epidermal growth factor (EGF) was kmdly donated bv 
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TA BLE 1. Effects of vanow, agents on BNP and ET- I ~ecret ion from cultured human amnion cells 
Agents 
Exp I 
\ 'ehtde control 
Estradiol f I x 10 moi/Ll 
Proge~terone II x 10-• mol/Ll 
Exp 2 
\' ehtcle control 
Norepinephrtne (I x 10 'moi/Ll 
Isoproterenol (I x 10-• moi/L) 
Dopamine (I x 10-6 moi/L) 
Exp 3 
\'ehtde control 
Dexametha<~one I I x 10 • moi/Ll 
Contsol II x 10 • mol LJ 
Exp 4 
Vehtcle control 
ET I (2 x 10 "moi/LI 
ET-:l (2 x 10 "moi/L) 
Exp 5 
Vehtde control 
8-Bromo·cGMP (1 x 10 moi/LI 
Exp 6 
Vehidt: control 
EGF 12 x )() 'mol/Ll 
Exp 7 
HNP secretion 
(fmol/10" cells · 72 h) 
246.:l ± 29.9 
215.1 ± 11.5 
251.2 ± 25.i' 
247.6 ± 20.0 
221.6 ± 41.6 
230.8 ± 27.8 
:.!06.9 ± 19.5 
282.2 ± 53.3 
I 1-1.0 ± 33.9" 
130.6 ± 19.7. 
2:18.5 ± 63.2 
203.8 ± 59.5 
236. 1 ± 23.4 
:l ll.O ± 25.1 
287.4 ± 17.2 
:198.1 ± 17.5 
29.9 ± 2.5• 
l~T l H~<·rPtlon 
(fmol/tO" ('(·II~ 72 hi 
126.0 ± I 1.4 
tO:l.9 ± 6.1 
103.5 ± 5.9 
163.0 ± i.O 
150.0± 10.1 
150.1 t 11.1 
152.7 + 12.() 
116.0 ± 14.4 
132.0 ± :17.9 




198.0 ± :19.4 
227.7 + 12.8 
89.9 ± 5,8 
252.2 + 1 I .9• 
Vehtclt: control 258.:! ± 42.6 178.7 ± 20.:l 
TGFff I.J x lO 1" mol/LI 1047.3 ± 4.3" 262.1-+: :u• --------------------~--------------------------------------~ -----------lluman amnion cells in rmmary monolayer culture were treated with vurious a~ents. After 72 h of incubation, culture media were samplt.>d. and 
BNP and ET-1 concentrations were determined, 11s drscrih~>d in MotrnaL<; and Methods. Data arc expressed as the menu+ SF-M of quadruplicnte 
rushes ND. Not determtned 
• P < 0.01 l'~. \'ehtcle controls. 
• P < 0.001 us. ' ·ehicle controls. 
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FtC. l. Time course of BNP ~ecretion from cultured amnion cells 
treated with dexamethasone and cortisol. Ten davs after the cells 
reached confluence, dexamethasone and conisol ~ere added to the 
culture medium, and t he cumulative amount of BNP secreted into the 
culture medium was determined by RIA. e. Vehicle control; 6. treat 
ment with I x 10-~ mol/L dexamethasone; 0, treatment with 1 x 10 ' 
moi/L conisol. \'alues are the mean ± SEM of quadruplicate dishel>. 
A~tPri.\k.\ indicate significant differences from the vehicle control ''alue~ 
at the o;ame incubation ume. ***· P < 0.001. The lime course of B:-JP 
secrellon from amnion cells treated with dexamethasone or conisol 
was ~ignificantly different from that in the vehirlt• C'Ontrol, as deter 
mtned by repeated measures of ANOVA (ANOVA and Fisher's pro· 
tected least significant difference test, P < 0.001 for both t·omparisons). 
Oht\uJ...a Pharmaceuhcal Co (Tokush1ma, japan) Tran~formmg growth 
factor·dl (TGFI31) and antt TGFdl rabbtt .. era w~re purchased from 
R & D Systems (Mtnneapoh~. \1'\) All other rl'agl'nh u~ed werl' of 
analytical grade and wer~ purcha~ed fwm Stgma Chemical Cn 
(St. Louis, MO). 
Experimental protocol 
A primary culture of human amnion celh ""'"conducted as dPScnbed 
previOusly (9, 13). The dtspersed ammon cell~ were collected by ccntrif 
ugation and resu.,pended tn Dulbecco·., Mtntmum Essential MediUm 
(DMEM) contamtng IOI'C. fetal calf serum (rCS) and seeded 2 x 10 
cells/well on a gelatin-coated 12-well plate The tncubation wa~ con 
dueled under an atmo'>phere of 5% C02 in air at 37 C. Every 2 d<~yl>, 
the medium was replaced with fresh DMEM cuntaining 10% FCS. 
Ten davs after the cells reached connuence, when BNP secretion 
from the a'mnion cello, became stable (9), the mediUm was replaced with 
fresh D\1EM contatntng IOI'C FCS, and the various substances listed tn 
Table I were added to the culture mcdtUm Del<amethasone, cort t~ol, 
estradiol, and proge~terone were diluted wtth IOOC'f ethanol, and thl• 
fmal concentration of ethanol in the culture medium was 0. I ~i. rhc 
same amount of ethc1nol wa~ added to the vehicle control, and ethanol 
at thi> concentration had no effect on the BNP secretion from cultured 
amnion cells. Isoproterenol, norepinephrine, and dopamine were diluted 
wtth I mmoi/L HCI ,1nd 0.1 mmoi/L L ascorbic acid, and the final 
concentrations of I!CI c1nd L·ascorbic acid in the culture medium were 
100 and 10 nmoi/L. rl·~pectively. ET-1 and ET 3 were diluted wtlh 20 
mmol/L potassium pho~phate buffer contatntng 0.5<:'( gelatin TGF/11 
w·a~ dtluted wtth 4 mmoi/L HCI contammg 0 I C'( BSA, and the final 
concentration of HCI tn the culture medtum was 100 nmoi/L. The saml' 
amount of HCI wa~ added to the vehtcll• control, and HCI at thts 
cuncentration did nut affect the pH of the medtum (pH 7.5). 8-Bromo 
cGMP was diluted wtth DMEM containing 10''( FCS. Every 24 h, an 
ahquot of the medium was sampled and o,tored with aprotinin (1000 
J...allikrcin inhibttor untts/mL), Triton-X (05':{ ), and EDTA di~odJUm salt 
(I mg/mL) at -20 C unit I assay The amounts of B\!P and ET-1 secr~ted 
from ammon cells were calculated from the lh,lngcs in 6'-JP and r· r 1 
leveb m the culture ml'dtUm, determmed by RIA 
.. 
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Ftc. 2. Dose-dependent effects of dexa-
methasone and cortisol on t he B::\P and 
ET-1 secretion from cultured amnion 
cells. Ten days after the cells reached 
confluence, various concentrations of 
dexamethasone or cortisol were added to 
the culture medium. Then, the total 
amounts ofBNP and ET-1 secreted from 
amnion cells mto the culture medium 
during 72 h of incubatton were deter 
mmed by RIA. \'alues are the mean ± 
SEM of quadruplicate dishes. Asten~ks 
indicate the significant differences from 
the vehicle-treated control values. *• P 
< 0.05; **· P < 0.01; ***· P < 0.001. A 
and B, Effect of dexamethasone on BNP 
secretion (A) and ET-1 secretion (8). (' 
and D. Effects of coni sol on B::\P secre· 
tion <Cl and ET·l secreuon (D). 






































The RIA for human BNP was performed using a specif1c monoclonal 
antibody (KY-hBNP-1) to human BNP, as described prevtously (6, 9). 
The cross reactivities of thiS RIA to human A, P, C tYpl' natnuretic 
peptide, and ET I were less than O.OOS"c, 0.5%, and O.S<:f on a molar 
basis, respectively. The sensitivity and 50% inhibitory concentration of 
this assay were 0.3 and 3 fmol/tube, respectively. 
The RIA for ET -1 was performed using a specific monoclonal antibody 
(KY·ET-1- !V) to ET-1, as described pre,•iously (10, 14). The cross-
reactivities of thts RIA to ET-2, ET ·3, and btg ET-1 were soc,, 20%, and 
80% on a molar basis, respecttvely The cross-reacbvtty of th1s RIA to 
human B P was less than 0 I o/c on a molar basis. The >en.,thVJty and 
50% inhibttory concentration of th1s a<;say were 0.2 and 0.6 fmol/tube, 
respectively. 
Bioassay for TGF{3 
The bioassay of TGFP was earned out as previously descnbed (15, 
16). In brief, CCL-64 mink lung epttheltal cells (17) were maculated at 
a density of 2 x 10' cells/well m 24 well plates 1 day before th~ assay 
ET AL JC'E o. :'.1•1994 
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~ ~ :\ )> Cont rol ° Control !b 
,<:> ,<:> ,<:> ,<:> ,<:> ,<:> ,<:> 
...... ...... ...... 
...... 
...... ...... ... ... 
Corllsol (M) Cortisol (M) 
ustng \1\tntmum Essential '\1edtUm and 0.1 mmol/L nonessential ammo 
aod (Ltfl• Tt.>chnolog1es, Grand bland, :\Y) with 10<1 FCS The subcon· 
flul'nt cell~ \\l're washed and mcubated wtth Oesh D\1h\1 contaming 
0.5"< FCS and TGFdl (5 320 pmoi/L), human amntohc Outd (2 5-20'1:) 
ubtamed from elective cesare.ln ~ection cases at term or from dtagnoshc 
amnwn•ntests in the .. econd trime~ter (16, 16, and 20 weeks of preg-
nancy), or conditioned medtum from amnion cell culture Twenty hours 
later, l'll)thymtdine (2 ~tCi/ml.) was added to thl' medtum, followed by 
further mcubation for 20 h Then. thl' amount of ['H]thymtdine incor· 
porated was determined by a hqutd scintillauon counter The growth 
mhtbttory l•ffect of TGF.dl and amntotlc fluid on CCL 64 was con finned 
by blockmg the growth tnhtbttOr\ effect by a rabbtt neutrahzmg ann 
TGFpl antibody 
Analysi.~ of data 
Value~ arc expresst.>d as the mean ± SEM. All expenments were 
conduded tn quadruplicate dtshe' The expenmenb were repeated at 
least thrt'l' hme;, to conftrm the re<.ults Statishcal analy~ts of the result~ 
,,,l., puformed by Student'., t test or anal)'S~ of \'ananct> (A:\0\'A) 
followed by Fisher's protected least ~tgntficant dtfference test when the 
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F ro. 3. Time course of BNP secretion from cultured amnion cells 
treated with EGF. Ten days after the cells reached conlluence, 2 x 10 " 
mol/L EGF were added to the culture medium, and the cumulative 
amount of BNP secreted into the culture medium was determined by 
RIA. e. BNP secretion in the vehicle control: 0, BNP secretion from 
amnion cells treated with EGF. Values a re the mean ± SEM of quad-
ruplicate dishes. Asteri.~k~ indicate significant differences from the 
vehicle control values at the same incubation time. ***• P < 0.001. 
The time course of BNP secretion from EGF-treated amnion cells was 
significantly different from that of the vehicle control by repeated 
measures of ANOVA (ANOVA and Fisher's protected least significant 
difference test, P < 0.00 I). 
means of more than two groups were compared The differences with 
P < 0.05 were regarded as s1gnificant. 
Results 
Effects of various agents on BN P and ET-1 secretion from 
cultured amnion cells 
Table 1 summarizes the effects of various agents on BNP 
secretion from cultured amnion cells. Estradiol (1 x 1 o-• 
mol/L); progesterone (1 X 10-' mol/L); norepinephrine, iso-
proterenol, and dopamine (1 X 10-• mol/Leach); ET-1 (2 x 
Frc. 4. Dose-dependent effects of EGF 
on BNP (A) and ET-1 (8) secretion from 
cultured amnion cells. Ten days after the 
cells reached confluence, various concen-
trations of EGF were added to t he cul-
ture medium. Then, the total amounts 
of BNP and ET-1 secreted from amnion 
cells into the culture medium during 72 
h of incubation were determined by RIA. 
Values are the mean ± SEM of quadru· 
plicate dishes. Asterisks indicate signifi· 
cant differences from the vehicle control 




10-~ mol/L); ET-3 (2 X 10-H moi/L); and 8-bromo cGMP (1 
X 10-' mol/L) had no effect on BNP and ET-1 secretion. 
On the other hand, dexamethasone (1 X 1 0 n mol/L), 
cortisol (1 X 10-• moi/L), and EGF (2 x 10_q moi/L) signifi-
cantly suppressed BNP secretion from cultured amnion cells. 
In contrast, TGF{J (4 X 10- 10 mol/L) stimulated BNP secre-
tion. In the same experiment, dexamethasone and cortisol 
did not affect ET -1 secretion. However, EGF and TGF{J 
significantly stimulated ET -1 secretion. 
Effects of glucocorticoid.s on BNP secretion from cultured 
amnion cel/.s 
Figure 1 shows the time course of BNP secretion from 
cultured amnion cells in the absence or presence of gluco-
corticoids. BNP secretion from amnion cells was markedly 
suppressed by the addition of 1 X 10- 6 mol/L dexamethasone 
to 29.1% and 11.0% of the vehicle control value at 24 and 
96 h of incubation, respectively. As illustrated in Fig. 1, the 
addition of 1 x 10- 6 moi/L cortisol also significantly sup-
pressed BNP secretion from cultured amnion cells to 39.5% 
and 18.7% of the vehicle control value at 24 and 96 h of 
incubation, respectively. 
Figure 2, A and C, shows the dose-dependent inhibition 
of BNP secretion by dexamethasone and cortisol, respec-
tively. BNP secretion was inhibited 50% by dexamethasone 
and cortisol at 1.2 x 10-R and 8.5 X 10-- moi/L, respectively. 
On the other hand, ET-1 secretion from cultured amnion 
cells was not affected by the same treatments with dexa-
methasone or cortisol (Fig. 2, B and D). 
Effects of EGF on BNP secretion frum cultured amnion cells 
As illustrated in Fig. 3, the addition of 2 X 1 o-" mol/L 
EGF markedly suppressed BNP secretion from amnion cells 
(31.6% and 7.2% of the vehicle control value after 24 and 
96 h of incubation, respectively). As shown in Fig. 4A, such 
an inhibition by EGF of BNP secretion from cu ltured amnion 
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Frc. fi. Time course of BNP secretion from cultured amnion cells 
treated with TGFJj. Ten days after the cells reached confluence, 4 x 
10' 10 mol/L TGFfj were added to the culture medium, and the cumu-
lative amount of BNP secreted into the culture medium was determined 
by RIA. e, BNP secretion in the vehicle control: 0 , BNP secretion 
from amnion cells treated with 4 X 10-w mol/L TGF/3. Values are the 
mean ± SEM of quadruplicate dishes. Asterisks indicate significant 
differences from the vehicle control values at the same incubation time. 
* · P < 0.05; ***· P < 0.001. The time course of BNP secretion from 
TGF/3-treated amnion cells was significantly different from that in the 
vehicle control by repeated measures of ANOV A (ANOVA and Fisher's 
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FrG. 6. Dose-dependent effects of TGF/3 on BNP (A) and ET-1 (B) 
secretion from cultured amnion cells. Ten days after the cell~ rearhed 
conlluence, various concentrations of EGF were added t.o the culture 
medium. Then, the total amounts of BNP and ET-1 secreted from 
amnion cells into culture medium during 72 h of incubation were 
determined by RIA. Values are the mean ± SEM of quadruplicflte 
dishes. Asteri.~ks indicate significant differences from the vehicle con-
trol values. *• P < 0.05: **· P < 0.01: ***• P < 0.001. 
by EGF at I X 10- 111 moi/L. 
In contrast, as shown in Fig. 46, ET-1 secretion from 
amnion cells was enhanced dose-dependently by the addi-
tion of 2 x 1 o-111 to 2 x I 0 " moi/L EGF. ET 1 secrPtion was 
stimulatPd by 2 x 10 ° mol/L FGF to a 3-fold higher level 
than that of the vehicle control. The concentration of EGF 
required tor half max1mal stimulation was 3 5 x 10- 10 mol/ 
L. 
Effects of TGF/3 on BNP secretwn from cultured amnion cells 
Figure 5 shows the time course of BNP secretion from 
cultured amnion cells stimulated by 4 x 10- 10 mol/L TGFf! 
BNP secretio11 from cultured amn.ion cells during 96 h of 
incubation in the presence of 4 x 10- 10 mol/ L TGF,B was 5-
fold higher than that in the vehicle control As illustrated in 
Fig. 6A, this stimulation by TGF13 of BNP secretion during 
72 h of incubation was dose dependPnt The concentration 
of TGFf! requiled for half maximal stimulation was 2.1 X 
w -ll moi/L. 
On the otl'\er hand, 4 x 10 11 to 4 x 10 .q mol/L TGF{J 
only slightly augmented ET-1 secretion from cultured am· 
nion cells (Fig 68). The amount of E1-l secreted in the 
presence of 4 x 10 • mol/L FGF \-\as 150% of that secreted 
in the vehicle control cultute 
Effects of corti-~ol and EUF on TGF/3 irui.ucPd RNP secretwn 
from cultwed amnion celL~ 
The effects of cortisol and EGF on BNP secretion aug-
mented by 4 X 10- 11' moi/L TGF/3 were examined. As shown 
in Fig. 7 A, the augmentation of BNP secretion by TGF.8 was 
dose dependently suppressed by cortisol. EGF also dose 
dependent!\• suppressed 1 GF/3 stimulated BNP secretion 
(fig 76) 
netection of biolonically actiue TGF(i in human amniotic fluid 
The growth-suppressive activity of TGF/3 has been de 
tected in the human amniotic fluid by a growth rnhibition 
assay using CCJ,-64 mink lung epithelial cells. TGF/1 concen-
tration" in the amniotic fluid in the <>econd trimester and at 
term were estimated to be 4 33 ± 54 pmol/1 (mean ± SEM; n 
= 3) and 410 ± 137 pmol/L (n = 1), respectively. This 
growth-suppressive activity of amniotic fluid was blocked by 
a rabbit anti-TGF/31 neutralizing antibody and was increased 
4 to 5 fold by acid treatment of the amniotic fluid samples, 
indicating activation of the latent form of TGF/3 by acid 
treatment (18) (data not shown). On the other hand, the 
growth-suppressive activity of TGF{J was not detected in the 
conditioned medium of amnion cell culture (<20 pmol/t) 
Discussion 
Among the agents examined in this study, dexamethasone, 
cortisol, and EGF suppressed BNP secretion from cultured 
amnion cells. By contrast, TGF.8 augmented BNP secretion 
The augmentation by TGF/3 was blocked by simultaneous 
treatment with cortisol or EGF. 
As cortisol is the most abundant glucocorticoid in the 
human amniotic fluid (19), we examined the effects of cor· 
tisol on BNP secretion from cultured amnion cells. Cortisol 
in human amniotic fluid originates from fetal urine, and the 
concentration of cortic;ol in the amniotic fluid increases dur-
ing pregnancy from 1 x 10 ~ mol/L in the second trimester 
BNP SECRETION FROM HUMAN AMNION CELLS 181 
(A) 
2000 
FIG. 7. Effects of cortisol (A) and EGF 
~ (8) on TGFP-induced BNP secretion 
"i from cultured amnion cells. Ten days u 
"' after the cells reached confluence, var- 0 1500 
ious amounts of cortisol or EGF were 0 
added to the culture medium together ~ 
with 4 x 10- 10 moi/L TGFp. The total c 
amounts ofBNP and ET-1 secreted from .2 1000 
amnion cells into culture medium during 
c; 
~ 
72 h of incubation were determined by ~ 
a. RIA. Values are the mean ± SEM of z 500 
quadruplicate dishes. #, Significantly (P Ill 
< 0.001) different from the vehicle con-
trol value. 
***· 
Significantly (P < 
0.001 l different from the value with 4 x 
0 10-'" moi/L TCFp alone. TGF·Il 
Cortisol 
to 1 X 10-· mol/L at term, reflecting the development of 
fetal adrenal gland (19, 20). In the present study, BNP 
secretion from cultured amnion cells was significantly sup-
pressed by the addition of 1 x 10·' moi/L cortisol, which 
resembles its physiOlogical concentration in amniotic fluid at 
term. However, a lower concentration of cortisol (1 x 10- 8 
mol/L) did not suppress BNP secretion. Thus, the increased 
concentration of cortisol in the amniotic fluid, which origi-
nates from the mature fetal adrenal gland, might act on the 
amnion tissue and suppress BNP secretion from amnion 
tissue at term. 
A large amount of EGF is present in human amniotic fluid 
at term (21, 22) EGF in amniotic fluid is postulated to be 
involved in the initiation of human labor by stimulating 
prostaglandin production in amnion cells (23, 24). In the 
present study, 2 x 10- 11 to 2 x 10-" moi/L EGF dose 
dependently inhibited BNP secretion from cultured amnion 
cells. The EGF leveltn human amniotic fluid increases grad-
ually up to 2 x 10- 10 mol/L at term (21, 22). Kniss eta/. (24) 
reported that EGF m amniotic fluid is derived at least in part 
from fetal kidney Thus, the mature fetus at term may secrete 
an increasing amount of EGF into amniotic fluid in the form 
of fetal urine, and the increased concen tration of EGF might 
inhibit BNP secretion from amnion cells. 
The present study demonstrated that the bioactive TGFp 
(-400 pmoi/L) exists in the amniotic fluid in the second 
trimester and at term. TGF{j at 4 X 10- •u mol/L, the sa me 
order as the phy:.iolog1cal concentration in amniotic fluid, 
markedly enhdnced BNP secretion from cultured amnion 
cells. In the present study, TGF{j was not detected in the 
conctitioned medium uf amnion cell culture, suggesting that 
TGF(] in arnnio!Jc flUid did not originate from amnion cells. 
Although the exact origin of TGF/3 in the amniotic fluid has 
not been clanfied, several investigators have reported gene 
expression of TGF(J in human placental trophoblast (25) and 
human decidua (26). Thus, we :.peculate that BNP secretion 
from ammon ctlfs 1s regulated by TGFp secreted from tissues 
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quired to test this interesting hypothesis. 
TGF{j-augmented BNP secretion from cultured amnion 
cells was significantly suppressed by the addition of cortisol 
or EGF at concentratjons physiologically present in amniotic 
fluid at term. The TGF(j concentration in amniotic fluid at 
term was similar to that during the second trimester. There-
fore, these findings suggest that BNP secretion from amnion 
cells is augmented or maintained by TGFp during the second 
trimester when the concentrations of EGF and cortisol are 
low, and that BNP secretion might be suppressed by the 
increased levels of cortisol and EGF at term (19- 22). 
Thus, the marked changes in the BNP concentration in 
amniotic fluid during pregnancy can be explained by the 
actions of TGF/3, EGF, and cortisol. However, there remains 
a possibility that some other factors in amniotic fluid may 
contribute to the regulation of BNP secretion from amnion 
cells. Another possibility that may affect BNP secretion from 
amnion cells is that these agents are metaboljzed in vivo by 
peptidases in the amnion cells, and their activities change 
depending on gestational age. Further studies are required to 
examine such a possibility. 
Recently, Potvin and Varma (27) reported that ANP inhib-
ited tension development by the uterus of 10- to 14-day 
pregnant rats. Our preliminary observation showed the gene 
expression of receptor for ANP and BNP (ANP-A receptor) 
in human decidua and uterine smooth muscle in the second 
trimester (ltoh, H., and N. Sagawa, unpublished findings) . 
Moreover, our previous study demonstrated that BNP se-
creted from amnion cells may reach the tissues surrounding 
the amniotic cavity (9). Thus, BNP secreted from amnion 
cells might reach the tissues of decidua and myometrium 
and play some role in the maintenance of pregnancy, espe-
cially in the first and second trimesters, and the effect of 
BNP on these tissues may be attenuated at term when BNP 
secretion from amnion cells decreases markedly. Further 
studies on the biological activity of BNP on the tissues 
adjacent to the amniotic membrane, including decidua and 
182 ITOH ET AL. JCE& M·1994 
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myometrium, are required to confirm the role of amniotic 
BNP in the maintenance of human pregnancy. 
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